Themis Medicare rises on incorporating new subsidiary company
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Themis Medicare is currently trading at Rs. 902.00, up by 7.60 points or 0.85% from its previous closing of Rs. 894.40 on the BSE.
The scrip opened at Rs. 898.00 and has touched a high and low of Rs. 914.85 and Rs. 898.00 respectively. So far 1471 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1198.80 on 16-Aug-2021 and a 52 week low of Rs. 271.70 on 31-Mar-2021.
Last one week high and low of the scrip stood at Rs. 924.10 and Rs. 863.05 respectively. The current market cap of the company is Rs. 829.80 crore.
The promoters holding in the company stood at 67.18%, while Institutions and Non-Institutions held 0.01% and 32.81% respectively.
Themis Medicare has incorporated a new Subsidiary Company incorporated under the Companies Act 2006 as a private Company, that the Company is limited by shares, and the situation of its registered office is in England and Wales.
Name of the new Subsidiary Company is ‘CARPO INVESTMENTS’ and date of incorporation is December 22, 2021.
Themis Medicare is a research-based pharmaceutical company specializing in manufacture of a wide range of products for application areas like Pain Management, Critical Care and Anti-Infectives
